Sumitomo Mitsui Trust Holdings Inc. Has $27.49 Million Position in Veeva Systems Inc (VEEV)
Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of Veeva Systems Inc (NYSE:VEEV) by 10.4% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 357,679 shares of the technology company’s stock after purchasing an additional 33,713 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned 0.25% of Veeva Systems worth $27,491,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the stock. We Are One Seven LLC raised its position in shares of Veeva Systems by 147.6% in the 1st quarter. We Are One Seven LLC now owns 1,679 shares of the technology company’s stock worth $123,000 after acquiring an additional 1,001 shares in the last quarter. Next Century Growth Investors LLC bought a new position in shares of Veeva Systems in the 1st quarter worth about $130,000. Cerebellum GP LLC raised its position in shares of Veeva Systems by 1,645.0% in the 2nd quarter. Cerebellum GP LLC now owns 2,251 shares of the technology company’s stock worth $173,000 after acquiring an additional 2,122 shares in the last quarter. Diversified Trust Co bought a new position in shares of Veeva Systems in the 1st quarter worth about $200,000. Finally, Synovus Financial Corp bought a new position in shares of Veeva Systems in the 1st quarter worth about $201,000. 73.52% of the stock is owned by institutional investors and hedge funds.
In other Veeva Systems news, President Matthew J. Wallach sold 12,000 shares of Veeva Systems stock in a transaction dated Wednesday, July 11th. The stock was sold at an average price of $79.90, for a total transaction of $958,800.00. Following the completion of the transaction, the president now owns 12,000 shares in the company, valued at approximately $958,800. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Alan Mateo sold 876 shares of Veeva Systems stock in a transaction dated Tuesday, July 17th. The shares were sold at an average price of $81.32, for a total value of $71,236.32. Following the transaction, the executive vice president now owns 13,023 shares of the company’s stock, valued at approximately $1,059,030.36. The disclosure for this sale can be found here. Insiders have sold a total of 136,641 shares of company stock valued at $11,165,938 in the last quarter. Company insiders own 15.97% of the company’s stock.
Shares of Veeva Systems opened at $83.51 on Monday, Marketbeat Ratings reports. Veeva Systems Inc has a one year low of $52.17 and a one year high of $85.00. The stock has a market capitalization of $11.98 billion, a P/E ratio of 90.77, a PEG ratio of 4.62 and a beta of 1.38.
Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Thursday, May 24th. The technology company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.02. The business had revenue of $195.55 million during the quarter, compared to the consensus estimate of $188.92 million. Veeva Systems had a return on equity of 12.47% and a net margin of 20.78%. The company’s quarterly revenue was up 22.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.24 EPS. equities analysts anticipate that Veeva Systems Inc will post 1.02 earnings per share for the current fiscal year.
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, data solutions, and master data management solutions; and Veeva Vault, a cloud-based enterprise content management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.
Featured Story: Average Daily Trade Volume – What You Need to Know
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc (NYSE:VEEV).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.